CI Investments Inc
DGX icon

CI Investments Inc’s Quest Diagnostics DGX Stock Holding History

CI Investments Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$870K Buy
4,107
+2,798
+214% +$549K ﹤0.01% 560
2026
Q1 		$257K Sell
1,309
-120
-8% -$23.3K ﹤0.01% 570
2025
Q4 		$248K Sell
1,429
-398
-22% -$72.5K ﹤0.01% 594
2025
Q3 		$348K Sell
1,827
-967
-35% -$172K ﹤0.01% 583
2025
Q2 		$502K Sell
2,794
-365
-12% -$63.4K ﹤0.01% 519
2025
Q1 		$535K Sell
3,159
-1,084
-26% -$178K ﹤0.01% 513
2024
Q4 		$640K Buy
4,243
+1,332
+46% +$207K ﹤0.01% 478
2024
Q3 		$452K Sell
2,911
-71
-2% -$10.6K ﹤0.01% 500
2024
Q2 		$408K Sell
2,982
-406
-12% -$55.6K ﹤0.01% 506
2024
Q1 		$451K Buy
3,388
+1,528
+82% +$198K ﹤0.01% 496
2023
Q4 		$256K Sell
1,860
-309
-14% -$40.6K ﹤0.01% 567
2023
Q3 		$264K Sell
2,169
-295
-12% -$39.3K ﹤0.01% 563
2023
Q2 		$346K Buy
2,464
+1,175
+91% +$162K ﹤0.01% 540
2023
Q1 		$182K Buy
1,289
+797
+162% +$114K ﹤0.01% 602
2022
Q4 		$77K Buy
492
+170
+53% +$24.4K ﹤0.01% 815
2022
Q3 		$40K Buy
322
+136
+73% +$17.9K ﹤0.01% 878
2022
Q2 		$25K Sell
186
-441
-70% -$60.1K ﹤0.01% 939
2022
Q1 		$86K Sell
627
-35
-5% -$4.88K ﹤0.01% 882
2021
Q4 		$115K Sell
662
-3,066
-82% -$467K ﹤0.01% 866
2021
Q3 		$542K Buy
3,728
+521
+16% +$76.2K ﹤0.01% 589
2021
Q2 		$423K Buy
3,207
+1,249
+64% +$164K ﹤0.01% 644
2021
Q1 		$251K Sell
1,958
-142,055
-99% -$17.5M ﹤0.01% 633
2020
Q4 		$17.2M Sell
144,013
-90,342
-39% -$11M 0.08% 200
2020
Q3 		$26.8M Buy
+234,355
New +$27.7M 0.13% 142
2020
Q2 		– Sell
-994
Closed -$80K – 636
2020
Q1 		$80K Sell
994
-589
-37% -$61K ﹤0.01% 541
2019
Q4 		$169K Buy
1,583
+40
+3% +$4.17K ﹤0.01% 573
2019
Q3 		$165K Buy
+1,543
New +$158K ﹤0.01% 555

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

CI Investments Inc's DGX Position: Q2 2026 in Review

CI Investments Inc increased its Quest Diagnostics (DGX) stake by 214% in Q2 2026, buying an estimated $549K and bringing the position to 4,107 shares worth $870K. The position accounts for ﹤0.01% of the portfolio, ranked #560.

CI Investments Inc first reported a position in DGX in Q3 2019 and has held it in 27 quarters since. The position peaked at $26.8M in Q3 2020. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • CI Investments Inc held 4,107 shares of Quest Diagnostics worth $870K as of Q2 2026.
  • CI Investments Inc bought 2,798 Quest Diagnostics shares in Q2 2026, an estimated $549K.
  • Quest Diagnostics made up ﹤0.01% of CI Investments Inc's portfolio in Q2 2026, its #560 holding.
  • CI Investments Inc first reported a position in Quest Diagnostics in Q3 2019 and has held it in 27 quarters since.
  • CI Investments Inc's Quest Diagnostics position peaked at $26.8M in Q3 2020.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.